Patents by Inventor Sudipta Pal

Sudipta Pal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMERIZATION PROCESS THAT INCLUDE GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES AND CHAIN TRANSFER AGENTS
    Publication number: 20230348641
    Abstract: Embodiments of this disclosure are directed to polymerization process comprising contacting ethylene and optionally one or more ?-olefins in solution in the presence of one or more catalyst systems and a chain transfer agent, wherein the catalyst system comprises a metal-ligand complex according to formula (I).
    Type: Application
    Filed: January 29, 2021
    Publication date: November 2, 2023
    Applicant: Dow Global Technologies LLC
    Inventors: Rhett A. Baillie, Philip P. Fontaine, Johnathan E. DeLorbe, Rafael Huacuja, Evelyn Auyeung, Jerzy Klosin, Robert David Grigg, Sudipta Pal, Brad C. Bailey
  • COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE
    Publication number: 20230331725
    Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I) or Formula (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
    Type: Application
    Filed: June 16, 2023
    Publication date: October 19, 2023
    Inventors: Nadiya Sydorenko, Md Rauful Alam, Lukiana Amedzo, Suresh Babu, Ramil Y. Baiazitov, Scott J. Barraza, Anuradha Bhattacharyya, Gary Mitchell Karp, Nathaniel T. Kenton, Anthony R. Mazzotti, Young-Choon Moon, Nicholas W. Mszar, Jana Narasimhan, Sudipta Pal, Jigar S. Patel, Anthony Turpoff, Matthew G. Woll, Zhenrong Xu, Nanjing Zhang
  • Compounds for treating Huntington's disease
    Patent number: 11780839
    Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I) or Formula (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: October 10, 2023
    Assignee: PTC THERAPEUTICS, INC.
    Inventors: Nadiya Sydorenko, Md Rauful Alam, Lukiana Amedzo, Suresh Babu, Ramil Y. Baiazitov, Scott J. Barraza, Anuradha Bhattacharyya, Gary Mitchell Karp, Nathaniel T. Kenton, Anthony R. Mazzotti, Young-Choon Moon, Nicholas W. Mszar, Jana Narasimhan, Sudipta Pal, Jigar S. Patel, Anthony Turpoff, Matthew G. Woll, Zhenrong Xu, Nanjing Zhang
  • GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES
    Publication number: 20230183267
    Abstract: Embodiments of this disclosure are directed to catalyst systems comprising a metal-ligand complex according to formula (I):
    Type: Application
    Filed: September 7, 2022
    Publication date: June 15, 2023
    Applicant: Dow Global Technologies LLC
    Inventors: Rhett A. Baillie, Philip P. Fontaine, Jerzy Klosin, Todd D. Senecal, Johnathan E. DeLorbe, Rafael Huacuja, Evelyn Auyeung, Robert David Grigg, Sudipta Pal, Brad C. Bailey
  • GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES
    Publication number: 20230133760
    Abstract: Embodiments of this disclosure are directed to catalyst systems comprising a metal-ligand complex according to formula (I).
    Type: Application
    Filed: January 29, 2021
    Publication date: May 4, 2023
    Applicant: Dow Global Technologies LLC
    Inventors: Rhett A. Baillie, Philip P. Fontaine, Jerzy Klosin, Todd D. Senecal, Johnathan E. DeLorbe, Rafael Huacuja, Evelyn Auyeung, Robert David Grigg, Sudipta Pal, Brad C. Bailey
  • COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE
    Publication number: 20210024525
    Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I) or Formula (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
    Type: Application
    Filed: March 27, 2019
    Publication date: January 28, 2021
    Inventors: Nadiya Sydorenko, Md Rauful Alam, Lukiana Amedzo, Suresh Babu, Ramil Y. Baiazitov, Scott J. Barraza, Anuradha Bhattacharyya, Gary Mitchell Karp, Nathaniel T. Kenton, Anthony R. Mazzotti, Young-Choon Moon, Nicholas W. Mszar, Jana Narasimhan, Sudipta Pal, Jigar S. Patel, Anthony Turpoff, Matthew G. Woll, Zhenrong Xu, Nanjing Zhang